Michelle Mudge-Riley on leaving the traditional medical path, connecting science with business, and keeping patients at the center of biotech development.

Michelle's journey from medical school and pathology into biotech Why leaving the traditional physician path initially felt like failure Finding new ways to create an impact on patients Building a company to help physicians explore alternative careers Moving from entrepreneurship and consulting into biotech Why successful biotech requires both good science and a viable business strategy What the work of a Medical Director can look like Translating complex scientific and clinical data into meaningful decisions The importance of communication across regulatory, medical, statistical, and clinical teams Balancing objective clinical endpoints with patient-reported outcomes and quality of life Designing clinical development strategies for different patient populations and global markets Population representation and the applicability of clinical trial results Bridging trials, PK data, and alternative approaches to generating evidence The opportunities and uncertainties surrounding real-world data and real-world evidence Why registries can play an important role in clinical development Leadership, mentorship, and learning through conversations with others Why personal growth often requires deliberately becoming comfortable with being uncomfortable Dealing with rejection, uncertainty, and failure when changing careers Why believing that change is possible is often the first step toward actually creating it

Michelle closes the conversation with an optimistic idea: progress starts when people are willing to look at the way things are today and openly discuss how they could be different tomorrow.